Literature DB >> 29203546

Use of Proteins Identified through a Functional Genomic Screen To Develop a Protein Subunit Vaccine That Provides Significant Protection against Virulent Streptococcus suis in Pigs.

Susan L Brockmeier1, Crystal L Loving2, Tracy L Nicholson2, Jinhong Wang3, Sarah E Peters3, Lucy Weinert3, Roy Chaudhuri3, David J Seilly3, Paul R Langford4, Andrew Rycroft5, Brendan W Wren6, Duncan J Maskell3, Alexander W Tucker3.   

Abstract

Streptococcus suis is a bacterium that is commonly carried in the respiratory tract and that is also one of the most important invasive pathogens of swine, commonly causing meningitis, arthritis, and septicemia. Due to the existence of many serotypes and a wide range of immune evasion capabilities, efficacious vaccines are not readily available. The selection of S. suis protein candidates for inclusion in a vaccine was accomplished by identifying fitness genes through a functional genomics screen and selecting conserved predicted surface-associated proteins. Five candidate proteins were selected for evaluation in a vaccine trial and administered both intranasally and intramuscularly with one of two different adjuvant formulations. Clinical protection was evaluated by subsequent intranasal challenge with virulent S. suis While subunit vaccination with the S. suis proteins induced IgG antibodies to each individual protein and a cellular immune response to the pool of proteins and provided substantial protection from challenge with virulent S. suis, the immune response elicited and the degree of protection were dependent on the parenteral adjuvant given. Subunit vaccination induced IgG reactive against different S. suis serotypes, indicating a potential for cross protection.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Streptococcus suis; adjuvant; functional genomics; subunit; vaccine

Mesh:

Substances:

Year:  2018        PMID: 29203546      PMCID: PMC5820948          DOI: 10.1128/IAI.00559-17

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

Review 1.  Respiratory tract mucin genes and mucin glycoproteins in health and disease.

Authors:  Mary Callaghan Rose; Judith A Voynow
Journal:  Physiol Rev       Date:  2006-01       Impact factor: 37.312

2.  Distribution of capsular types and production of muramidase-released protein (MRP) and extracellular factor (EF) of Streptococcus suis strains isolated from diseased pigs in seven European countries.

Authors:  H J Wisselink; H E Smith; N Stockhofe-Zurwieden; K Peperkamp; U Vecht
Journal:  Vet Microbiol       Date:  2000-06-01       Impact factor: 3.293

3.  Characterization of the immune response and evaluation of the protective capacity of rSsnA against Streptococcus suis infection in pigs.

Authors:  Lidia Gómez-Gascón; Fernando Cardoso-Toset; Carmen Tarradas; Jaime Gómez-Laguna; Alfonso Maldonado; Jens Nielsen; Alfonso Olaya-Abril; Manuel J Rodríguez-Ortega; Inmaculada Luque
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2016-06-04       Impact factor: 2.268

4.  Production of muraminidase-released protein (MRP), extracellular factor (EF) and suilysin by field isolates of Streptococcus suis capsular types 2, 1/2, 9, 7 and 3 isolated from swine in France.

Authors:  F Berthelot-Hérault; H Morvan; A M Kéribin; M Gottschalk; M Kobisch
Journal:  Vet Res       Date:  2000 Sep-Oct       Impact factor: 3.683

5.  Intranasal vaccination with replication-defective adenovirus type 5 encoding influenza virus hemagglutinin elicits protective immunity to homologous challenge and partial protection to heterologous challenge in pigs.

Authors:  Douglas R Braucher; Jamie N Henningson; Crystal L Loving; Amy L Vincent; Eun Kim; Julia Steitz; Andrea A Gambotto; Marcus E Kehrli
Journal:  Clin Vaccine Immunol       Date:  2012-08-29

6.  Antibody response specific to the capsular polysaccharide is impaired in Streptococcus suis serotype 2-infected animals.

Authors:  Cynthia Calzas; Paul Lemire; Gael Auray; Volker Gerdts; Marcelo Gottschalk; Mariela Segura
Journal:  Infect Immun       Date:  2014-11-10       Impact factor: 3.441

7.  Phagocytosis and killing of Streptococcus suis by porcine neutrophils.

Authors:  Geneviève Chabot-Roy; Philip Willson; Mariela Segura; Sonia Lacouture; Marcelo Gottschalk
Journal:  Microb Pathog       Date:  2006-05-22       Impact factor: 3.738

8.  The molecular basis of glycogen breakdown and transport in Streptococcus pneumoniae.

Authors:  D Wade Abbott; Melanie A Higgins; Susanne Hyrnuik; Benjamin Pluvinage; Alicia Lammerts van Bueren; Alisdair B Boraston
Journal:  Mol Microbiol       Date:  2010-05-19       Impact factor: 3.501

9.  Mixed adjuvant formulations reveal a new combination that elicit antibody response comparable to Freund's adjuvants.

Authors:  Rachel P J Lai; Michael S Seaman; Paul Tonks; Frank Wegmann; David J Seilly; Simon D W Frost; Celia C LaBranche; David C Montefiori; Antu K Dey; Indresh K Srivastava; Quentin Sattentau; Susan W Barnett; Jonathan L Heeney
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

10.  Rapid evolution of virulence and drug resistance in the emerging zoonotic pathogen Streptococcus suis.

Authors:  Matthew T G Holden; Heidi Hauser; Mandy Sanders; Thi Hoa Ngo; Inna Cherevach; Ann Cronin; Ian Goodhead; Karen Mungall; Michael A Quail; Claire Price; Ester Rabbinowitsch; Sarah Sharp; Nicholas J Croucher; Tran Bich Chieu; Nguyen Thi Hoang Mai; To Song Diep; Nguyen Tran Chinh; Michael Kehoe; James A Leigh; Philip N Ward; Christopher G Dowson; Adrian M Whatmore; Neil Chanter; Pernille Iversen; Marcelo Gottschalk; Josh D Slater; Hilde E Smith; Brian G Spratt; Jianguo Xu; Changyun Ye; Stephen Bentley; Barclay G Barrell; Constance Schultsz; Duncan J Maskell; Julian Parkhill
Journal:  PLoS One       Date:  2009-07-15       Impact factor: 3.240

View more
  7 in total

1.  Chitosan Oligosaccharides Coupling Inhibits Bacterial Biofilm-Related Antibiotic Resistance against Florfenicol.

Authors:  Xianghua Yuan; Jing Liu; Ruilian Li; Junlin Zhou; Jinhua Wei; Siming Jiao; Zhuo A Wang; Yuguang Du
Journal:  Molecules       Date:  2020-12-21       Impact factor: 4.411

2.  Identifying virulence determinants of multidrug-resistant Klebsiella pneumoniae in Galleria mellonella.

Authors:  Sebastian Bruchmann; Theresa Feltwell; Julian Parkhill; Francesca L Short
Journal:  Pathog Dis       Date:  2021-03-20       Impact factor: 3.166

3.  Streptococcus suis Encodes Multiple Allelic Variants of a Phase-Variable Type III DNA Methyltransferase, ModS, That Control Distinct Phasevarions.

Authors:  Greg Tram; Freda E-C Jen; Zachary N Phillips; Jamie Timms; Asma-Ul Husna; Michael P Jennings; Patrick J Blackall; John M Atack
Journal:  mSphere       Date:  2021-05-12       Impact factor: 4.389

4.  Engineering Antigens to Assemble into Polymer Particle Vaccines for Prevention of Streptococcus suis Infection.

Authors:  Zennia Jean C Gonzaga; Shuxiong Chen; Mélanie Lehoux; Mariela Segura; Bernd H A Rehm
Journal:  Vaccines (Basel)       Date:  2021-11-24

Review 5.  The Role of Streptococcal Cell-Envelope Proteases in Bacterial Evasion of the Innate Immune System.

Authors:  Sophie McKenna; Kristin Krohn Huse; Sean Giblin; Max Pearson; Mohammed Said Majid Al Shibar; Shiranee Sriskandan; Stephen Matthews; James Edward Pease
Journal:  J Innate Immun       Date:  2021-10-14       Impact factor: 7.111

6.  Evaluation of the recombinant proteins RlpB and VacJ as a vaccine for protection against Glaesserella parasuis in pigs.

Authors:  Samantha J Hau; Shi-Lu Luan; Crystal L Loving; Tracy L Nicholson; Jinhong Wang; Sarah E Peters; David Seilly; Lucy A Weinert; Paul R Langford; Andrew N Rycroft; Brendan W Wren; Duncan J Maskell; Alexander W Tucker; Susan L Brockmeier
Journal:  BMC Vet Res       Date:  2020-05-27       Impact factor: 2.741

7.  Enolase and dipeptidyl peptidase IV protein sub-unit vaccines are not protective against a lethal Streptococcus suis serotype 2 challenge in a mouse model of infection.

Authors:  Audrey Dumesnil; Léa Martelet; Daniel Grenier; Jean-Philippe Auger; Josée Harel; Eric Nadeau; Marcelo Gottschalk
Journal:  BMC Vet Res       Date:  2019-12-10       Impact factor: 2.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.